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Abstract In human colon carcinoma HT-29 Glc t+ cells, 
L-arginine is the common precursor of polyamines which are 
absolutely necessary for cellular profiferation and nitric oxide 
(NO) with reported anti-proliferative activity. The aim of the 
present work was to test the effect of the NO donor sodium 
nitroprusside (SNP) on polyamine synthesis and cellular growth 
in HT-29 cells. SNP in the micromolar range inhibits cellular 
putrescine synthesis and this effect is greatly reversed by 
haemoglobin, supporting the view that the effect of SNP is 
related to the generation of NO. This corresponds to the 
inhibition by SNP of ornithine decarboxylase activity. Further- 
more, SNP inhibits cellular proliferation. The effect of SNP is 
reversed by haemoglobin after 2 days of treatment but not after 4 
days. Although no acute toxic effect of SNP was detected after 
90 min incubation, it greatly enhanced the cellular death rate 
after several days in culture as estimated by the LDH leakage 
test. In conclusion, our data raise the possibility of an inhibitory 
interrelationship between NO and polyamine metabolic path- 
ways. NO induced inhibition of putrescine synthesis and growth 
in HT-29 cells is discussed from a causal perspective. 
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I. Introduction 
Since normal  enterocytes isolated from the small intestine 
of mammals  do not survive for more than 1 h [1], intestinal 
cell prol iferation and differentiation may be analysed in ma- 
l ignant cells including HT-29 cells originating from a human 
colon carcinoma [2]. Differentiated HT-29 G lc -  cells are se- 
lected in a hexose-free culture medium [3]. In the present 
work, we used Glc HT-29 cells which have been switched 
back in a D-glucose-containing medium [4]. These cells, called 
Glc - /+ HT-29 cells, can spontaneously differentiate after con- 
fluency in enterocyte-like cells with an apical brush border 
membrane equipped with villin and dipeptidylpeptidase IV
[4,5]. Polyamines are involved in the proliferation/differentia- 
tion process [6]. In HT-29 cells, these polycations can be taken 
up from an extracellular medium or can be generated from 
amino acid precursors, mainly L-arginine [7]. L-Arginine is 
degraded into L-ornithine and urea by arginase. L-Ornithine 
is the precursor of putrescine, spermidine and spermine by the 
action of ornithine decarboxylase, spermidine synthase and 
spermine synthase respectively. In HT-29 cells, the inhibit ion 
of cellular synthesis of polyamines leads to the almost com- 
plete arrest of cellular prol iferation [8]. In HT-29 cells, a small 
part of L-arginine taken up is degraded into nitric oxide and 
L-citrulline [7]. NO is generally considered as anti-proliferative 
[9-16]. The fact that L-arginine is a precursor of metabolites 
with opposite effects on the cellular state led us to assess the 
effect of the NO donor  SNP on polyamine synthesis and cel- 
lular growth and differentiation. 
2. Materials and methods 
2.1. Chemicals 
All the ~4C-labelled molecules were purchased from Amersham or 
New England Nuclear. Gly-Pro p-nitroanilide, p-nitroaniline, sodium 
nitroprusside, bovine haemoglobin and putrescine dihydrochloride 
were from Sigma Chemicals. 
2.2. HT-29 cell culture and incubation 
HT-29 Glc /+ cells used in this study were kindly provided by A. 
Servin (Facult6 de Pharmacie, Ch~tenay-Malabry, France) and cul- 
tured in standard DMEM medium containing 10% foetal calf serum, 
25 mM D-glucose, 100 U/ml penicillin and 100 p.g/ml streptomycin 
exactly as described [7]. HT-29 Glc -/+ cells were used between pas- 
sages 62 and 77 (1 passage very 7 days) and were seeded at a density 
of 0.40× 106 cells per 25 cm 2 on day 0. The culture medium with or 
without the tested agents was changed every day and cells were iso- 
lated with EDTA-trypsin phosphate-buffered saline [7] and counted 
with a haemacytometer. The cells were washed and incubated in 
Krebs-Henseleit bicarbonate-buffered medium (pH 7.4) saturated 
with a mixture of O2-CO2 (19:1, v/v) containing 10 mM HEPES, 
1.3 mM CaC12, 2 mM MgCI2 and enriched with 10 mg/ml bovine 
serum albumin. Radioactive urea, putrescine and spermidine were 
separated by HPLC using a C18 partisphere column (Whatman) as 
described elsewhere [17]. Incorporation of L-[U-14C]leucine into pro- 
teins was measured after precipitation of proteins with 10% trichloro- 
acetic acid. Oxidation of L-[U-14C]glutamine was determined by meas- 
uring 14CO2 as described previously [17]. Nitrite was assayed using 
Griess reagent [18]. Basal cell content in nitrite represented 172_+ 39 
pmol/106 cells at the end of incubation (n-- 5). 
2.3. Enzyme activities 
Dipeptidylpeptidase IV was assayed using the method of Nagatsu 
[19] in sonicated cells recovered from the flask with a cell scraper. The 
assay medium was a 71 mM glycine/NaOH buffer, pH 8.7 containing 
1 mM phenylmethylsulfonyl fluoride. Ornithine decarboxylase activity 
was determined in sonicated cells by decarboxylation of L- 
[1-HC]ornithine as described [17]. Lactate dehydrogenase (LDH) leak- 
age test was performed by measuring the activity of this cytosolic 
enzyme in the culture medium or in the adhering cells as described 
elsewhere [1]. 
2.4. Presentation of results 
The results were expressed as the mean (+ S.E.M.) together with 
the number of individual experiments performed with HT-29 cells 
isolated at different passages (n). The production of radioactive me- 
tabolites from precursors was calculated by reference to the specific 
activity of the precursors in the incubation medium. The statistical 
significance of differences between mean values was assessed by 
Student's t-test. 
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3. Resu l ts  
3.1. Nitrite synthesis JJ'om SNP 
When l0 laM SNP was added for 90 min at 37°C in the 
incubation medium, 0.35_+ 0.09 BM nitrite (n = 5) was meas- 
ured. When the cells were incubated in the presence of 10 ~tM 
SNP, the production of nitrite from SNP averaged 128_+ 30 
pmol/106 cells per 90 min (n = 5). 
3.2. Effect of SNP on polyamine synthesis 
SNP (10 I, tM) inhibited the synthesis of radioactive putres- 
cine from 0.1 mM L-[U-14C]ornithine (Fig. 1). In the presence 
of both SNP (10 p.M) and haemoglobin (30 BM), the inhibi- 
tory effect of SNP was partly reversed. Haemoglobin alone 
has no effect on putrescine synthesis. The production of sper- 
midine from L-ornithine was also affected by SNP (10 jaM). 
Indeed, basal spermidine production (i.e. 47_+ 15 pmol/106 
cells per 90 min, n--4) was slightly but significantly reduced 
(25 _+ 7% inhibition, n = 4, p < 0.05 vs. basal). When SNP was 
used at a concentration equal to 1 BM, the inhibitory effect on 
putrescine production was equal to 18 + 4% (n -- 3, p < 0.05 vs. 
basal). The inhibition of the flux of L-ornithine through or- 
nithine decarboxylase in isolated cells corresponded to an in- 
hibitory effect of SNP on ODC activity (Fig. 2). 
The basal production of radioactive urea from 0.4 mM 
L-[guanido-~aC]arginine by HT-29 cells was not affected by 
10 I, tM SNP indicating that SNP did not affect the flux of 
L-arginine through arginase (data not shown). 
3.3. Effect of SNP on cellular growth, metabolism, viability and 
differentiation 
The effect of SNP on cellular growth was then assessed 
(Fig. 3). SNP induced in a dose-dependent manner a decrease 
in the number of HT-29 cells recovered in the flask. The effect 
of haemoglobin on SNP induced inhibition of cellular growth 
was investigated by adding haemoglobin at the same time as 
SNP. On day 3, haemoglobin reversed the effect of SNP (Fig. 
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Fig. I. Effect of SNP and haemoglobin on putrescine production 
from 0.1 mM u-[U-1~C]ornithine by HT-29 cells. HT-29 cells were 
isolated 5 days after seeding. Results are expressed as mean value 
(_+ S.E.M.) and represent 4 individual experiments. Basal putrescine 
production was equal to 1607_+559 pmol/106 cells per 90 rain. 
**p < 0.025 vs. SNP alone, ***p < 0.001 vs. basal. 
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Fig. 2. Effect of SNP on ODC activity. Homogenates of HT-29 cells 
recovered 5 6 days after seeding were incubated in the presence of 
200 pM L-[l-14C]ornithine and increasing concentrations of SNP. 
The basal ODC activity represented 200+71 pmol/106 cells per h. 
Results are expressed as mean value (_+S.E.M.) and represent 5-8 
individual experiments. **p < 0.005 vs. basal, ***p < 0.001 vs. basal. 
4). It should be noted that haemoglobin alone significantly 
inhibited HT-29 cell growth. 
However, on day 5, haemoglobin was unable to reverse 
significantly the effect of 10 BM SNP. Hence, the number of 
cells recovered in the presence of 30 pM haemoglobin was 
equal to 4.67 + 1.21 l0 G cells per flask. In the presence of 10 
pM SNP or 10 pM SNP with 30 gM haemoglobin, the num- 
ber of cells was equal to 0.27+0.05 and 0.84+0.54 106 per 
flask, respectively (n--3). Furthermore, when putrescine was 
added at a concentration of 10 gM with 10 I, tM SNP, it did 
not reverse the effect of SNP either on days 3, 5 or 7. Thus, 
the number of cells recovered per flask in the presence of 
putrescine and SNP was 0.14+0.06, 0.16+0.04 and 
0.06+0.01 10 ~ on days 3, 5 and 7, respectively. The number 
of cells recovered in the sole presence of 10 I, tM SNP was 
0.16+0.08, 0.18_+0.06 and 0.12_+0.05 106 per flask (n=3 in 
all cases). 
The effect of SNP on cell death rate was estimated by the 
LDH leakage test (Table 1). It should be pointed out that on 
day 3 and in the absence of SNP, the percentage of LDH 
Table 1 
Effect of SNP on cell death rate 
SNP (I~M) Percentage of dead cells 
Day 3 Day 5 Day 7 
0 23+8 (3) 3-+1 (4) 3-+1 (4) 
0.1 ND 5_+1 (4) 4_+1 (4) 
1.0 ND 52_+15(4) 27_+11 (3) 
10.0 58+9 (4) 83_+4 (4) 72_+8 (4) 
Percentage of dead cells was estimated by calculating the ratio of 
LDH activity in the culture medium as a percentage of total LDH 
activity (i.e. the sum of LDH activity in culture medium and adhering 
cells). ND, not determined. LDH total activity in nmol/min per 
flask=day 3, basal (no SNP)= 1205-+316, 10 l.tM SNP=973- + 184; 
day 5, basal=5417_+650, .1 l.tM SNP=3672+615, 1 BM 
SNP= 892-+233, 10 l, tM SNP= 580_+ 306; day 7, basal= 12396+745, 
0.1 BM SNP=7733+898, 1.0 ~tM SNP 1986+815, 10 ~tM 
SNP = 250_+ 85. 
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Fig. 3. Effect of SNP on HT29 cell growth. SNP was added 1 day 
after seeding and the culture medium with or without SNP was 
changed every day. Cells were isolated with trypsin and counted at 
different periods of time. Results are expressed as mean values 
(+ S.E.M.) and represent 512 individual experiments. 
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Fig. 4. Effect of SNP and haemoglobin on HTI29 cells growth. 
SNP and haemoglobin were added together 1 day after seeding and 
the culture medium with or without the agents tested was changed 
every day. The cells were isolated and counted 3 days after seeding. 
Results are expressed as mean values (+ S.E.M.) and represent 5 in- 
dividual experiments; *p < 0.05 vs. SNP alone, **p < 0.025 vs. basal, 
***p < 0.001 vs. basal. 
recovered in the culture medium was relatively high, indicat- 
ing cell death in the early days of culture after treatment with 
trypsin and seeding. It was found that 1 gM or more of SNP 
seriously affected the viability of HT-29 cells. It should noted 
that the remaining adhering cells were apparently not greatly 
affected by SNP in term of viability. Thus, the basal cellular 
viability on days 3, 5 or 7 as measured by the trypan blue 
exclusion test (i.e. 84 + 2%, n = 11), remained unchanged in the 
presence of 1 gM SNP (84 + 3%, n = 8) and was slightly re- 
duced in the presence of 10/aM SNP (69+6, n= 11, p<0.05  
vs. basal). 
The effect of SNP was then tested on different metabolism 
and viability parameters on short-term cellular incubation 
(Table 2). It was observed that 10 gM SNP exerted no effect 
on the 3 parameters tested. The treatment with increasing 
concentrations of SNP did not lead to any significant increase 
in the activity of dipeptidyl peptidase IV (Table 3). 
4.  D iscuss ion  
Our data demonstrate that putrescine synthesis in isolated 
HT-29 cells can be strongly inhibited by 10 gM SNP while 1 
gM exerts a weak inhibitory effect. 
This effect was reversed by the addition of haemoglobin 
which suggests that SNP acts as a NO donor. Indeed, the 
affinity of haemoglobin for NO is very high [20]. Under our 
incubation conditions, and in the absence of cells, 10 ~tM SNP 
released 0.35 pM nitrite. This would correspond to the spon- 
taneous release of NO from SNP since it has been shown that 
Table 2 
Effect of SNP on cell metabolism and viability 
in aerobic aqueous solutions, the primary degradation prod- 
uct of NO is nitrite [21]. It is worth noting that HT-29 cells 
are able to produce nitrite from SNP. This would correspond 
to the cellular generation of NO from SNP as recently demon- 
strated in rat liver microsomes [22]. Thus, NO produced spon- 
taneously or generated from SNP by HT-29 cells would in- 
hibit putrescine synthesis. This inhibition is apparently due to 
that of ornithine decarboxylase (ODC) activity as demon- 
strated in the present study. ODC is a proto-oncogene which 
is a key regulator for cell growth and malignant ransforma- 
tion [23]. Polyamines modulate the transcription of growth 
associated genes in human colon carcinoma cells [24] and 
putrescine is involved in DNA,  RNA and protein synthesis 
in intestinal epithelial cells [25]. 
This led us to test the effect of SNP on HT-29 cell prolif- 
eration. The inhibitory effect was marked for a concentration 
equal to 1 laM and total at 10 pM. The effect could be re- 
versed by haemoglobin after 2 days of treatment, but not after 
4 days indicating that the effect of SNP was due to NO pro- 
duction in the first case. In contrast, the effect of SNP after 4 
days of culture does not seem to be primarily due to NO 
synthesis. Although the influence of SNP on cell growth is 
not a mere short-term toxic effect as measured from viability 
or metabolism parameters uch as protein synthesis or gluta- 
mine oxidation, SNP from concentrations equal to 1 laM acts 
on cellular viability after several days in culture. 
It may therefore be asked whether inhibition of putrescine 
synthesis in HT-29 cells by SNP plays a role in the decrease of 
cell viability and growth. The fact that putrescine added to the 
Basal SNP (10 pM) 
Incorporation of 1 mM L-[UJ4C]leucine into proteins (nmol/106 cells per 90 min) 2.34+0.96 (3) 2.51 + 1.11 (3) 
Oxidation of 2 mM L-[U-14C]glutamine (nmol/106 cells per 90 min) 4.69 + 1.30 (3) 4.93 +0.66 (3) 
Trypan blue viabilityafter 90 min incubation (% viable cells) 93 + 2 (3) 94 + 1 (3) 
Cells were isolated 5 days after seeding. 
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Table 3 
Effect of SNP on HT-29 dipeptidyl peptidase IV activity 
SNP (gM) Day 3 Day 5 Day 7 
0 12.2+1.1 (4) 14.3+1.7 (4) 20.5+_3.3 (4)
0.1 14.5_+0.3 (3) 17.0_+2.1 (3) 23.6_+4.5 (3)
1.0 15.8_+2.3 (3) 13.3_+2.1 (4) 14.7_+0.1 (3)
10.0 21.1 _+4.0 (4) ND 22.0_+3.7 (3) 
ND, not determined. DPP IV activity was measured in adhering cells 
recovered with a cell scraper. Results are expressed as mU/mg protein 
(1 mU=l nmol/min). 
culture medium does not reverse the SNP effect suggests that 
although inhibition of putrescine synthesis by NO could play 
a role in the inhibitory effect on growth after 2 days of cul- 
ture, this would not be the primary target. Hence, when an 
ODC inhibitor, namely difluoromethylornithine, was added to 
the culture medium of HT-29 cells, it inhibited cell growth, an 
effect which could be reversed by adding putrescine [8]. 
Our data show an extreme sensitivity of HT-29 cells to 
SNP. In other investigations, millimolar concentrations of 
SNP have been used to alter significantly cell proliferation 
[2628]. SNP-induced cytotoxicity has been shown to be due 
to NO release in hepatocytes [29]. SNP has been used as a 
differentiating agent in several cell types [28,30]. However, in 
the present study, SNP did not alter the activity of the differ- 
entiation marker dipeptidylpeptidase IV. In conclusion, our 
data support the idea of a regulation of polyamine synthesis 
by NO in HT-29 cells, suggesting the possibility of interfer- 
ence between two metabolic pathways derived from the com- 
mon precursor L-arginine. NO synthase activity is low in HT- 
29 cells [7] but recent data suggest hat the production of NO 
increases in HT-29 cells by a combination of cytokines [31]. 
Further studies are required to determine the effect of cellular 
NO overproduction on cell growth. 
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